Niche Tech & Infrastructure Overhaul: Edge AI, Drone Defense, and Capital Moves

I'm told that a flurry of niche U.S. technology and infrastructure players are quietly orchestrating significant capital moves and strategic pivots this quarter. According to people familiar with the matter, companies ranging from edge AI to advanced manufacturing and healthcare are racing to lock in fresh funding, divest legacy assets, and secure specialized contracts before the end of the year. This is shaping up to be the most significant structural overhaul for this secondary market segment since 2025.

Flex (FLEX.US)

Advanced manufacturing heavyweight Flex has seen its stock outperform the broader sector this year. I'm told the company is accelerating the planned spin-off of its cloud and power infrastructure business, which is slated for completion in Q1 of fiscal 2027. Meanwhile, Flex is quietly expanding its partnership with Cerebras to ramp up the manufacturing of AI supercomputers in the U.S. by a factor of seven. The company recently posted strong Q1 FY2027 revenue of USD 7.9B, topping estimates with an adjusted EPS of USD 1.00.

Veea (VEEA.US)

Edge AI and cybersecurity firm Veea is making aggressive commercial pushes. The company launched its VigiLynx service via Telcel in Mexico in July. According to people familiar with the matter, the U.S. regulated Alternative Trading System has set an early August 2026 listing date for the firm. The stock has seen volatility recently amid a series of financial maneuvers, including an S-3 shelf registration for up to USD 75M in securities.

Thermo Fisher Scientific (TMO.US)

Medical research giant Thermo Fisher Scientific has maintained a steady trajectory this year. The company just delivered a solid Q2, reporting revenue of USD 11.99B—a 10.5% year-over-year jump—and adjusted EPS of USD 6.03, beating consensus estimates on both the top and bottom lines. I'm told the firm, which sold off its microbiology business to Astorg earlier this year, recently patched a critical vulnerability in its Applied Biosystems human identification software.

HubSpot (HUBS.US)

Marketing platform HubSpot is in a quiet period ahead of its upcoming earnings report and has trended downward over the past month. The market expects the company to post 18% year-over-year revenue growth for Q2. HubSpot already generated USD 881M in Q1 2026. Internal chatter suggests that the upcoming UNBOUND 26 event in the fall will serve as a major launchpad for its next-generation AI marketing tools.

ParaZero Technologies (PRZO.US)

Drone defense firm ParaZero is experiencing a surge in orders, which has helped the stock rebound recently. Over the past two months, the company has secured multiple orders for its DefendAir Net Pods from Tier-1 defense manufacturers in Europe, Israel, and the U.S. Crucially, they are partnering with Axon Vision to integrate their physical interception nets with edge AI-driven defense systems.

Also

• Generate Biomedicines (GENB.US): The generative biology company is sitting on roughly USD 516M in cash as of Q1. I'm told its Phase 3 clinical trials for the GB-0895 asthma drug are well underway, with another key solid tumor program expected to begin dosing later this year.
• STAK Inc. (STAK.US): Originally focused on oilfield equipment and NEVs, STAK is executing a major pivot. I'm told the company is establishing a U.S. subsidiary to provide modular power generation systems for AI data centers. Its NEV business brought in RMB 62.6M in cumulative revenue over the nine months ending March 2026.
• Swvl Holdings (SWVL.US): The mass transit tech provider is aggressively expanding its footprint in the Middle East. It reported a 68% year-over-year revenue increase to USD 8.2M in Q1 and recently landed a shuttle service contract for the banking sector in Saudi Arabia.
• Ohmyhome (OMH.US): The Singapore-based proptech firm has underperformed the sector this year. I'm told the company sold its core real estate business for a nominal USD 1 and just priced a USD 4M direct offering to help address NASDAQ minimum bid price issues.
• Elong Power (ELPW.US): Lithium-ion battery maker Elong Power announced a registered offering to raise approximately USD 1.38M at USD 0.12 per unit. The company had to execute a 1-for-80 reverse stock split earlier this year just to maintain its listing status.

This article does not constitute investment advice.